TargetMacrophage migration inhibitory factor(Rattus norvegicus)
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Affinity DataIC50: 3.70E+3nMAssay Description:Inhibition of recombinant rat MIF expressed in Escherichia coli BL21 (DE3) assessed as reduction in tautomerase activity using L-dopachrome carboxy-m...More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Rattus norvegicus)
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of recombinant rat MIF expressed in Escherichia coli BL21 (DE3) assessed as reduction in tautomerase activity using L-dopachrome carboxy-m...More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Rattus norvegicus)
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of recombinant rat MIF expressed in Escherichia coli BL21 (DE3) assessed as reduction in tautomerase activity using L-dopachrome carboxy-m...More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Rattus norvegicus)
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of recombinant rat MIF expressed in Escherichia coli BL21 (DE3) assessed as reduction in tautomerase activity using L-dopachrome carboxy-m...More data for this Ligand-Target Pair
TargetMacrophage migration inhibitory factor(Rattus norvegicus)
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Takeda Pharmaceutical Co. Ltd.
Curated by ChEMBL
Affinity DataIC50: 6.80E+4nMAssay Description:Inhibition of recombinant rat MIF expressed in Escherichia coli BL21 (DE3) assessed as reduction in tautomerase activity using L-dopachrome carboxy-m...More data for this Ligand-Target Pair





3D Structure (crystal)